Trending...
- Registered Nurse Launches Healthcare Wealth Strategy Practice for Healthcare Professionals
- UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
- SelfCare is now HealthCare across America
SHF 2.0 Framework as Practical Solution to Drive Continuous Improvement
MIDDLETOWN, N.Y. - OhioPen -- Ongoing research reveals a notable gap between present practices and the essential best practices needed for successful Human Factors Engineering (HFE) projects. This underlines a significant obstacle within the medical device industry – the ineffective implementation of HFE. The issue has become more apparent in recent years, as the Food and Drug Administration (FDA) now reviews HFE project results as part of their quality system regulation (QSR). Disturbingly, over 90% of HFE submissions are reportedly rejected by the FDA, due to deficiencies.
The Critical Role of Human Factors Engineering (HFE) in the Medical Device Industry
Human Factors Engineering (HFE) has a pivotal role in the medical device industry, serving as the intersection of human capabilities and system operations. It significantly contributes to safety, efficiency, and user experience. However, project failure can result in device designs that jeopardize effective and safe usage.
Pioneering this area of research, Dr. Katia M. Rojas, an expert in project management and operational excellence, has been studying the underlying causes of these project failures. Her groundbreaking research began during her Ph.D. studies in Industrial & Systems Engineering at Binghamton University.
Dr. Rojas' work has unveiled substantial insights into the root causes of failures and the crucial success factors in FDA HFE validation projects. Such observations have led her to assert that HFE validations are currently project managed at relatively low maturity levels, which significantly impacts project quality and success rates. This emphasizes the need for an industry-focused project management maturity framework to facilitate the standardization of emerging best practices.
More on Ohio Pen
"By focusing on improving project management maturity, particularly emphasizing the key success factors or best practices, we can drastically cut down the current 90% rejection rate at the FDA," said Dr. Rojas. "This approach not only addresses the pressing challenges in the medical device industry, but also promises improved project outcomes and enhanced patient safety."
Unveiling a Silent Crisis: Importance of Addressing Findings
In the fast-paced world where innovation and patient safety converge, patients are heavily reliant on the successful application of human factors engineering during medical device development. However, "the unsatisfactory application of HFE has subtly transformed into a silent crisis," Dr. Rojas pointed out.
The alarming FDA rejection rates highlight the urgent need for proactive engagement from key stakeholders to implement corrective measures. Nevertheless, the lack of such engagement raises concerns about the effectiveness of any current interventions aimed at reducing the persistently high failure rate.
Introducing the Successful Human Factors™ 2.0 (SHF 2.0) Framework
To address these challenges, Dr. Rojas introduces the Successful Human Factors™ 2.0 (SHF 2.0) framework. SHF 2.0 is a researched-based maturity framework designed to optimize HF projects by focusing on key success factors, particularly those related to the delivery of an HFE Validation Report for FDA review. This approach will enable HF service providers (HFSPs) to refine their processes, establish consistent practices, and uphold the highest standards in medical device HFE.
Effectiveness of the SHF 2.0 Framework in Enhancing HF Project Management Maturity
A study investigating the effectiveness of the SHF 2.0 framework found that the average maturity level of successful HF projects corresponded to "Level 2 – Childhood" in the framework, revealing significant variations and a lack of standardization in implementing HFE best practices for medical devices. These findings underline the urgent need for a more standardized and consistent approach in the field.
More on Ohio Pen
Initial investigations validating the SHF 2.0 framework have demonstrated its potential and reliability as a tool for improving the maturity of HF project management. Participants of the study recognized its potential to enhance the success rates of HF submissions.
These key findings have been consolidated in a pre-print publication titled "Validating a Project Management Maturity Framework Based on Emerging Best Practices for Successful Human Factors Projects Requiring FDA Approval – Summary of Key Findings," which is available on ResearchGate.
Future Outlook: Ongoing Research and Embracing the Long Road Ahead
"While the urgent need for improved HF project management practices in the medical device industry is apparent, stakeholders may still be in the early stages of understanding the value of the SHF 2.0 framework," Dr. Rojas noted, acknowledging the long journey ahead. "Broader adoption of the SHF 2.0 framework can significantly improve HF project outcomes, contributing to progress in HFE within the medical device industry."
The SHF 2.0 framework is designed for continuous improvement, encouraging HFSPs to benchmark their performance against industry standards and best practices. This drive towards excellence fosters innovation and creates new industry benchmarks.
To learn more about SHF 2.0, participate in ongoing industry-wide benchmark research, or explore the current industry maturity level report, visit: https://www.successfulhf.com/
The Critical Role of Human Factors Engineering (HFE) in the Medical Device Industry
Human Factors Engineering (HFE) has a pivotal role in the medical device industry, serving as the intersection of human capabilities and system operations. It significantly contributes to safety, efficiency, and user experience. However, project failure can result in device designs that jeopardize effective and safe usage.
Pioneering this area of research, Dr. Katia M. Rojas, an expert in project management and operational excellence, has been studying the underlying causes of these project failures. Her groundbreaking research began during her Ph.D. studies in Industrial & Systems Engineering at Binghamton University.
Dr. Rojas' work has unveiled substantial insights into the root causes of failures and the crucial success factors in FDA HFE validation projects. Such observations have led her to assert that HFE validations are currently project managed at relatively low maturity levels, which significantly impacts project quality and success rates. This emphasizes the need for an industry-focused project management maturity framework to facilitate the standardization of emerging best practices.
More on Ohio Pen
- Architect of Neurodiversity Will Lead the First U.S. Team of Autistic Children to the "Genius Cup" in Hiroshima, Japan, in 2027
- BevWire Report: Sparkling Wine Categories Evolve as Prosecco and Asti DOCG Announce Expansion
- Deborah E. Jones Introduces Emotional Sovereignty, a Powerful New Book on Emotional Mastery, Resilience, and Intentional Living
- New Research Identifies "The Busy Effect": 89% of Americans Want a Laid-Back Vacation — Only 15% Actually Achieve It
- Alchemy 43 Appoints Shane Smith as CEO to Drive Operational Performance and Scalable Growth
"By focusing on improving project management maturity, particularly emphasizing the key success factors or best practices, we can drastically cut down the current 90% rejection rate at the FDA," said Dr. Rojas. "This approach not only addresses the pressing challenges in the medical device industry, but also promises improved project outcomes and enhanced patient safety."
Unveiling a Silent Crisis: Importance of Addressing Findings
In the fast-paced world where innovation and patient safety converge, patients are heavily reliant on the successful application of human factors engineering during medical device development. However, "the unsatisfactory application of HFE has subtly transformed into a silent crisis," Dr. Rojas pointed out.
The alarming FDA rejection rates highlight the urgent need for proactive engagement from key stakeholders to implement corrective measures. Nevertheless, the lack of such engagement raises concerns about the effectiveness of any current interventions aimed at reducing the persistently high failure rate.
Introducing the Successful Human Factors™ 2.0 (SHF 2.0) Framework
To address these challenges, Dr. Rojas introduces the Successful Human Factors™ 2.0 (SHF 2.0) framework. SHF 2.0 is a researched-based maturity framework designed to optimize HF projects by focusing on key success factors, particularly those related to the delivery of an HFE Validation Report for FDA review. This approach will enable HF service providers (HFSPs) to refine their processes, establish consistent practices, and uphold the highest standards in medical device HFE.
Effectiveness of the SHF 2.0 Framework in Enhancing HF Project Management Maturity
A study investigating the effectiveness of the SHF 2.0 framework found that the average maturity level of successful HF projects corresponded to "Level 2 – Childhood" in the framework, revealing significant variations and a lack of standardization in implementing HFE best practices for medical devices. These findings underline the urgent need for a more standardized and consistent approach in the field.
More on Ohio Pen
- Best Spiritual Healing, Meditation & Retreats in Sedona — Rise Meditation Helps You Find and Book Transformational Experiences
- $16 Billion Market by 2034 in Underwater Drones Presents Huge Opportunity for AI-Powered Autonomous Vehicle Serving Defense & Commercial Customers
- Appliance EMT Named Among Jacksonville's Top 3 Appliance Repair Companies by ThreeBestRated®
- Matthew Cossolotto Launches Countdown to "Make a Promise Day" (May 4th) and New Book -- Harness Your PromisePower – with Jack Canfield Foreword
- Geekstorians Nominated For Best History Podcast In The 30th Annual Webby Awards
Initial investigations validating the SHF 2.0 framework have demonstrated its potential and reliability as a tool for improving the maturity of HF project management. Participants of the study recognized its potential to enhance the success rates of HF submissions.
These key findings have been consolidated in a pre-print publication titled "Validating a Project Management Maturity Framework Based on Emerging Best Practices for Successful Human Factors Projects Requiring FDA Approval – Summary of Key Findings," which is available on ResearchGate.
Future Outlook: Ongoing Research and Embracing the Long Road Ahead
"While the urgent need for improved HF project management practices in the medical device industry is apparent, stakeholders may still be in the early stages of understanding the value of the SHF 2.0 framework," Dr. Rojas noted, acknowledging the long journey ahead. "Broader adoption of the SHF 2.0 framework can significantly improve HF project outcomes, contributing to progress in HFE within the medical device industry."
The SHF 2.0 framework is designed for continuous improvement, encouraging HFSPs to benchmark their performance against industry standards and best practices. This drive towards excellence fosters innovation and creates new industry benchmarks.
To learn more about SHF 2.0, participate in ongoing industry-wide benchmark research, or explore the current industry maturity level report, visit: https://www.successfulhf.com/
Source: Successful Human Factors™
0 Comments
Latest on Ohio Pen
- IQSTEL accelerates toward profitability inflection with $317M revenue and AI-driven expansion; IQSTEL Inc. (N A S D A Q: IQST) i
- AI-Driven Breakthrough Unleashed: Bionic Intelligence Platform Goes Live to Capture Massive Biotech Opportunity: KALA BIO, Inc. (N A S D A Q: KALA)
- Surging Into Hyper-Growth Mode With Record Revenue, Raised 2026 Guidance, and Game-Changing AI Platform; Off The Hook YS (NYSE American: OTH)
- Mom Creators Coalition Launches with WaterWipes® as Official Founding Sponsor
- PandaGuarantee Launches Rent Guarantor Service in New York City
- The $112M Marketing Lesson Joe Whyte Learned: Why 'More Traffic' Is the Biggest Lie in Digital Marketing
- Daniel Kaufman Expands Kaufman & Company Real Estate Platform With New Acquisitions, AI-Driven Industrial Development and Nationwide Growth Initiative
- purelyIV Launches Lab Testing Services in Metro Detroit
- On the 296th Anniversary of the Ceremony That Made His Ancestor Emperor, a Cherokee Descendant Publishes the Novel That Restores Him
- NRx Pharmaceuticals Could Be on the Verge of a Breakout Year as AI, FDA Catalysts, and Mental Health Demand Converge
- DC Accounting Firm Offers Free Business CRM to Small Business Clients Alongside Weekly Bookkeeping Model
- CCHR: Psychiatric Drugs Fuel Rising Death Toll: National Adverse Drug Event Awareness Day Confronts America's Medication Crisis
- Explosive $10 Billion Counter-Drone Market with AI-Powered Defense Ecosystem: ZenaTech, Inc. (N A S D A Q: ZENA)
- High-Value Execution Phase Begins: Bitcoin Bancorp Ignites Texas Rollout of Digital Asset ATM Network: Bitcoin Bancorp (Stock Symbol: BCBC) $BCBC
- New Indie Author Only Bookstore
- UK Financial Ltd Tokenized LTNS 1, A $1.1 T Asset-Backed ERC-3643 Security Token with 11 On-Chain Contracts Verifying, Compliant Real-World Value
- SelfCare is now HealthCare across America
- Homeowner Prep Announces Strategic Language Shift: Replacing "Renters" with "Future Homeowners" to Inspire Wealth-Building Mindsets
- LiposoMore™ Redefines Bioavailability: Joyful Nutritional Launches High-Performance Liposomal Vitamin C and Iron for the Global Supplement Market
- GDE Tree Services Expands Operations into Sydney, NSW
